Introducing Kapsul ATLAS protective athletic gear
With revolutionary Dynamic Neck Stabilization Technology The biomechanically-tested neck protective shirts empower every athlete to do what they love for longer—no matter their age or skill level. WATERLOO, ON, Dec. 15, 2022 /PRNewswire/ -- Kapsul Tech Corp. today announced the Kapsul ATLAS, a lightweight and flexible shirt with a protective collar designed...
Sirnaomics Announces Positive Interim Data from Phase IIb Clinical Trial of STP705 in Adults with Cutaneous Squamous Cell Carcinoma In Situ
Dose escalation cohort study is evaluating the safety, tolerability and efficacy of various doses of STP705 administered as intralesional injection in subjects with isSCC GERMANTOWN, Md. and SUZHOU BIOBAY, China, Dec. 14, 2022 /PRNewswire/ -- Sirnaomics Ltd. (the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today the interim...
Actinogen announces first patient treated in depression and cognitive impairment Phase 2 clinical trial
Approximately 5% of Americans suffer from Major Depressive Disorder (MDD), which is commonly associated with "foggy thinking" but a new clinical trial raises hope that once-a-day oral drug Xanamem® may assist where treatment by anti-depressant medication alone is inadequate SYDNEY, Dec. 14, 2022 /PRNewswire/ -- Actinogen Medical Limited (ASX: ACW) is pleased to announce that...
E-Home Household Services Holdings Limited’s subsidiary Zhong Run Launches Cloud Pharmacy Service to Address New Situation of Epidemic Prevention and Control
FUZHOU, China, Dec. 14, 2022 /PRNewswire/ -- E-Home Household Service Holdings Limited (Nasdaq: EJH) (the "Company" or "E-Home"), a provider of integrated household services in China, today announced that the Company's subsidiary Zhongrun (Fujian) Pharmaceutical Co., Ltd. ("Zhongrun") plan to expand market coverage and medical product offerings via online and offline sales networks in China. Recently, the Joint Prevention...
Hovione and GEA announce a strategic collaboration to advance Continuous Tableting
LISBON, Portugal, Dec. 14, 2022 /PRNewswire/ -- Hovione and GEA today announced a strategic collaboration to advance Continuous Tableting. This partnership stemmed from a successful customer-supplier relationship spanning several years. It combines GEA´s engineering expertise with Hovione´s development and manufacturing experience and both parties commit to partner to accelerate the adoption of Continuous Tableting technology. Navin Lakhanpaul,...
SWISS REJU wins prestigious COSMOPOLITAN “Best of the Best” beauty award, taking innovative slimming and body contouring to the next level
HONG KONG, Dec. 14, 2022 /PRNewswire/ -- SWISS REJU, a high-end beauty brand located at the heart of Central Hong Kong, is thrilled to announce it has been honored with the "COSMOPOLITAN Best of the Best Panel's Choice Award", a much coveted prize for beauty brands. Each year, thousands of new beauty products and services are launched into the...
Circulating Tumor Cell detection by Menarini Group’s CELLSEARCH® System leading to genomic profiling of myeloma cells shows potential for non-invasive management of Multiple Myeloma patients at early stages of...
Researchers at Dana-Farber Cancer Institute showed that enumeration of circulating tumor cells (CTCs) with Menarini Silicon Biosystems' CELLSEARCH® System and the CELLSERCH® Circulating Multiple Myeloma Cell (CMMC) Test* can be used to monitor and manage patients with Multiple Myeloma (MM) even at asymptomatic precursor stages HUNTINGDON VALLEY, Pa., Dec. 14, 2022 /PRNewswire/ -- Menarini...
BPK9 International Hospital Achieves GHA Accreditation for Medical Travel Services
PALM BEACH GARDENS, Fla., Dec. 14, 2022 /PRNewswire/ -- Global Healthcare Accreditation (GHA) is pleased to announce that BPK9 International Hospital in Bangkok, Thailand (https://www.bangpakokhospital.com/en/) is awarded with GHA Accreditation for Medical Travel Services. BPK9 International Hospital is one of the leading private hospitals in Thailand, offering local and international patients access to an expert team of doctors, the...
Another very successful year for the ZEISS Group
Significant revenue growth of 8.8 billion euros despite challenging geopolitical and economic conditions – EBIT at 1.6 billion euros (up 109 million euros compared to the prior year). The ZEISS Group once again significantly surpassed the strong prior-year level. All four ZEISS segments have shown double-digit percentage growth Focused investment strategy with high expenditure on research and development...
Superior Results Of The Comparative Study Of The Company’s Recombinant Two-Component COVID-19 Vaccine ReCOV As Compared To International Mainstream mRNA Vaccine
TAIZHOU, China, Dec. 14, 2022 /PRNewswire/ -- Jiangsu Recbio Technology Co., Ltd. (the "Company", together with its subsidiaries, the "Group") is pleased to announce that positive results were achieved for its sequential booster vaccination Phase II study of the recombinant twocomponent COVID-19 vaccine ReCOV in the Philippines. This clinical study aims...
